Pacjenci z zespołem jelita drażliwego wykazują istotne zaburzenia mikroflory jelitowej

1. Ahrné, S., Nobaek, S., Jeppsson, B., Adlerberth, I., Wold, A., and Molin, G. (1998). The normal Lactobacillus flora of healthy human rectal and oral mucosa, J. Appl. Microbiol. 85: 88-94.
2. Kassinen A, Krogius-Kurrika L., Makivuokko H. i wsp. (2007). The Fecal Microbiota of Irritable Bowel Syndrome Patients Differs Significantly From That of Healthy Subjects. Gastroenterology 133; 24-33
3. Molin, G., Jeppsson, B., Ahrné, S., Johansson, M.-L., Nobaek, S., Stahl, M., and Bengmark, S. (1993). Numerical taxonomy of Lactobacillus spp. associated with healthy and diseased mucosa of the human intestines, J. Appl. Bacteriol. 74: 314-323.

1. Hütt, P., Shchepetova, J., Loivukene, K., Kullisaar, T. and Mikelsaar, M. (2006). Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and urpathogens. Journal of Applied Microbiology 100: 1324-1332
2. Mack, D.R., Michail, S., Wei, S., McDougall L., and Hollingsworth, M.A. (1999).Probiotics inhibit enteropathogenic E.coli adherence in vitro by inducing intestinal mucin gene expression, Am. J. Physiol. 276: G941-G950.
3. Mack, D.R., Ahrné, S., Hyde, L., Wei, S. and Hollingsworth, M.A. (2003). Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 52: 827-833.
4. Mangell, P., Nejdfors, P., Wang, M., Ahrné, S., Weström, B., Thorlacius, H., and Jeppsson, B. (2002). Lactobacillus plantarum 299v inhibits Escherichia coli-induced intestinal permeability, Digestive Diseases and Sciences 47: 511-516.

1. Johansson, M-L., Nobaek, S., Berggren, A., Nyman, M., Björck, I., Ahrné, S., Jeppsson, B., and Molin, G. (1998). Survival of Lactobacillus plantarum DSM 9843 (299v), and effect on the short-chain fatty acid content in faeces after ingestion of a rose-hip drink with fermented oats, Int. J. Fd. Microbiol. 42: 29-38.
2. Niedzielin, K., Kordecki, H., and Birkenfeld, B. (2001). A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299v in patients with irritable bowel syndrome, Eur. J. Gastroenterol. Hepatology 13: 1143-1147.
3. Nobaek, S., Johansson, M-L., Molin, G., Ahrné, S., and Jeppsson, B. (2000). Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome, Am. J. Gastroenterol. 95: 1231-1238.
4. Sen, S., Mullan, M.M., Parker, T.J., Woolner, J.T., Tarry, S.A. and Hunter, J.O. (2002).Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome. Digestive Diseases and Sciences 47: 2615-2620

1. Adawi, D., Kasravi, F.B., Molin, G., and Jeppsson, B. (1997). Effect of Lactobacillus supplementation with and without arginine on liver damage and bacterial translocation inan acute liver injury model, Hepatology 25: 642-647.
2. Adawi, D., Molin, G., Ahrné, S., and Jeppsson, B. (2002). Safety of the probiotic strain Lactobacillus plantarum DSM 9843 ( = strain 299v) in an endocarditis animal model, Microb. Ecol. Health Dis., 14: 50-53.
3. Adlerberth, I., Ahrné, S., Johansson, M-L., Molin, G., Hanson, L-A., and Wold, A.E. (1996). A mannose-specific adherence mechanism in Lactobacillus plantarum conferring binding to the human colonic cell line HT-29, Appl. Environ. Microbiol., 62: 2244-2251. Aguirre, M. and Collins, M.D. (1993). Lactic acid bacteria and human clinical infection, J. Appl. Bacteriol. 75: 95-107.
4. Berggren, A., Söderberg, L., Önning, G., Johansson Hagslätt, M-L. and Axelsson, I. (2003). Intestinal function, microflora and nutrient intake of children after administration of a fermented oat product containing Lactobacillus plantarum DSM 9843 (299v). Microbial Ecology in Health and Disease 15: 160-168.
5. Bukowska, H., Pieczul-Mróz, J., Jastrzebsk, K., Chelstowski, K., and Naruszewicz, M. (1998). Significant decrease in fibrinogen and LDL-cholesterol levels upon supplementation of the diet with Lactobacillus plantarum (ProViva) in subjects with moderately elevated cholesterol concentrations, Atherosclerosis, 137: 437-438.
6. Cunningham-Rundles, S., Ahrné, S., and Bengmark, S. (2000). Probiotics and immune response. Am. J. Gastroenterol. 95 (1, Supplement, 2000): S22-S25.
7. Cunningham-Rundles, S., Ahrné, S., Abuav-Nissbaum, B.S., and Dnistrian, A. (2002).Development of immunocompetence: role of micronutrients and microorganisms,Nutrition Reviews 60 (5): S68-S72.
8. Goossens, D., Jonkers, D., Russel, M., Stobberingh, E., van den Bogaard, A. and Stockbrügger, R. (2003). The effect of Lactobacillus plantarum 299v on the bacterial composition and metabolic activity in faeces of healthy volunteers: a placebo-controlled study on the onset and duration of effects. Alliment. Pharmacol. Ther. 18: 495-505.
9. Goossens, D., Jonkers, D., Russel, M., Thijs, A., van den Bogaard, A., Stobberingh, E. andStockbrügger, R. (2005). Survival of the probiotic, L. plantarum 299v and its effect on thefaecal bacterial flora, with and without gastric acid inhibition. Digestive and Liver Disease37: 44-50.
10. Goossens, D., Jonkers, D., Russel, M., Stobberingh, E. and Stockbrügger, R. (2006a). The effect of a probiotic drink with L. plantarum 299v on the bacterial composition in faeces and mucosal biopsies of rectum and ascending colon. Alimentary Pharmacology & Therapeutics 23: 255-263.
11. Goossens, D., Jonkers, D., Stobberingh, E., Molin, G., Ahrné, S., Russel, M., and Stockbrügger, R. (2006b). The faecal and mucosal bacterial composition of patients with inactive UC: can it be changed by L. plantarum 299v? In: The effect of the probiotic L. plantarum 299v on the intestinal flora: Methodological studies in health and disease. PhDthesis by D. Goossens. Chapter 6. The Nutrition and Toxicology Research Institute Maastricht, Maastricht, 2006.
12. Goossens, D., Jonkers, D., Russel, M., Vaughan, E., Stobberingh, E., and Stockbrügger, R.(2006c). Bowel cleansing with subsequent intake of Lactobacillus plantarum 299v does not change the composition of the faecal flora. Microbial Ecology in Health and Disease. 18: 139-146.
13. Hütt, P., Shchepetova, J., Loivukene, K., Kullisaar, T. and Mikelsaar, M. (2006). Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and urpathogens. Journal of Applied Microbiology 100: 1324-1332.
14. Johansson, M.-L., Molin, G., Jeppsson, B., Nobaek, S., Ahrné, S., and Bengmark, S.(1993). Administration of different Lactobacillus strains in fermented oatmeal soup: In vivo colonization of human intestinal mucosa and effect on the indigenous flora, Appl.Environ. Microbiol. 59: 15-20.
15. Johansson, M-L., Nobaek, S., Berggren, A., Nyman, M., Björck, I., Ahrné, S., Jeppsson, B., and Molin, G. (1998). Survival of Lactobacillus plantarum DSM 9843 (299v), and effect on the short-chain fatty acid content in faeces after ingestion of a rose-hip drink with fermented oats, Int. J. Fd. Microbiol. 42: 29-38.
16. Klarin, B., Johansson, M-L., Molin, G., Larsson, A., Jeppsson, B. (2005). Adhesion of the probiotic bacterium Lactobacillus plantarum 299v onto the gut mucosa in critically ill patients: a randomised open trial. Critical Care 9: R285-R293.
17. Liu, Q., Nobaek, S., Adawi, D., Mao, Y., Wang, M., Molin, G., Ekelund, M., and Jeppsson, B. (2001). Administration of Lactobacillus plantarum 299v reduces side effects of external radiation on colonic anastomotic healing in an experimental model, Colorectal Disease 3: 245-252.
18. Mangiante, G, Colucci, G., Canepari, P., Bassi, C., Nicoli, N., Casaril, A., Marinello, P., and Bengmark, S. (2001). Lactobacillus plantarum reduces infection of pancreatic necrosis in experimental acute pancreatitis, Digest. Surg. 18: 47-50.
19. Mao, Y., Nobaek, S., Adawi, D., Molin, G., and Jeppsson, B. (1997). Comparison of the effects of different Lactobacillus strains in reducing bacterial translocation on Methotrexate induced enterocolitis in rats, Digest. Surg. 14: 284-291.
20. McCracken, V.J, Chun, T., Baldeón, M.E., Ahrné, S., Molin, G., Mackie, R.I. & Gaskins, H.R. (2002). TNF-α sensitizes HT-29 colonic epithelial cells to intestinal lactobacilli. Experimental Biology and Medicine 227: 665-670.
21. McNaught, C.E., Woodcock, N.P., MacFie, J and Mitchell, C.J. (2002). A prospective randomised study of the probiotic Lactobacillus plantarum 299v on indices of gut barrier function in elective surgical patients. Gut 51: 827-831.
22. Michail, S. and Abernathy, F. (2002). Lactobacillus plantarum reduces the in vitro secretory response of intestinal epithelial cells to enteropathogenic Escherichia coli infection. Journal of Pediatric Gastroenterology and Nutrition 35: 350-355.
23. Molin, G. (2001). Probiotics in foods not containing milk or milk constituents, with special reference to Lactobacillus plantarum 299v, Am. J. Clin. Nutr. 73 (Iss. 2; Suppl. S): 380S-385S.
24. Molin, G. (2003). The role of Lactobacillus plantarum in foods and in human health. In: Handbook of Fermented Functional Foods. chap. 13; pp. 305-342. E. R. Farnworth (ed).CRC Press, Boca Raton, London, New York, Washington, D.C.
25. Naruszewicz, M., Johansson, M-L., Zapolska-Downar, D., and Bukowska, H. (2002).Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers,Am. J. Clin. Nutr., 76: 1249-1255.
26. Niedzielin, K., Kordecki, H., and Birkenfeld, B. (2001). A controlled, double-blind,randomized study on the efficacy of Lactobacillus plantarum 299v in patients with irritable bowel syndrome, Eur. J. Gastroenterol. Hepatology 13: 1143-1147.
27. Nobaek, S., Johansson, M-L., Molin, G., Ahrné, S., and Jeppsson, B. (2000). Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome, Am. J. Gastroenterol. 95: 1231-1238.
28. Olah, A., Belagyi, T., Issekutz, A., Gamal, M.E. and Bengmark, S. (2002). Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. British Journal of Surgery 89: 1103-1107.
29. Önning, G., Berggren, A., Drevelius, M., Jeppsson, B., Lindberg, A.-M., Johansson Hagslätt, M.-L. (2003). Influence of a drink containing different antioxidants and Lactobacillus plantarum 299v on plasma total antioxidant capacity, selenium staus and faecal microbial flora. International Journal of Food Sciences and Nutrition 54: 281-289.
30. Osman, N., Adawi, D., Ahrne, S., Jeppsson, B. & Molin, G. (2004). Modulation of the effect of dextran sulfate sodium-induced acute colitis by the administration of different probiotic strains of Lactobacillus and Bifidobacterium. Digestive Diseases and Sciences 42: 320-327.
31. Rayes, N., Seehofer, D., Hansen, S., Boucsein, K., Muller, A.R., Serke, S., Bengmark, S. and Neuhaus, P. (2002b). Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 15:123-127.
32. Schultz, M., Veltkamp, C., Dieleman, L.A., Grenther, W.B., Wyrick, P.B., Tonkonogy, S.L., and Sartor, R.B. (2002). Lactobacillus plantarum 299v in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflamm. Bowl. Dis. 8: 71-80.
33. Sen, S., Mullan, M.M., Parker, T.J., Woolner, J.T., Tarry, S.A. and Hunter, J.O. (2002). Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome. Digestive Diseases and Sciences 47: 2615-2620.
34. Stjernquist-Desatnik, A., Warfving, H. and Johansson, M-L. (2000). Persistence of Lactobacillus plantarum DSM 9843 on human tonsillar surface after oral administration in fermented oatmeal gruel. Acta Otolaryngol (Suppl.) 543: 215-219.
35. Vanderhoof, J.A., Young, R.J., Murray, N. and Kaufman, S.S. (1998). Treatment strategies for small bowel bacterial overgrowth in short bowel syndrome. Journal of Pedriatric Gastroenterology and Nutrition 27: 155-160.
36. Veltkamp, C., Tonkongy, S.L., Schulz, M. et al. (1999). Lactobacillus plantarum is superior to Lactobacillus GG in preventing colitis in IL-10 deficient mice [Abstract]. Gastroenterology 116: A838.
37. Wullt, M., Johansson Hagslätt, M.-L. and Odenholt, I. (2003). Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficille-associated diarrhoea: A doubleblind placebo-controlled trial. Scandinavian Journal of Infect. Dis. 35: 365-367.